Efficacy and Safety of Deucravacitinib in Adults with Alopecia Areata
Phase 2
- Conditions
- Alopecia Areata
- Registration Number
- JPRN-jRCT2031220610
- Lead Sponsor
- Fuentes Duculan David
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Documented clinical diagnosis of AA for at least 6 months
Alopecia Areata Investigator Global Assessment ( AA-IGA)
grade >- 3
Exclusion Criteria
Other active skin diseases affecting the scalp that in the opinion of the investigator may interfere with accurate assessment of SALT score
History or evidence of active infection and/or febrile illness
Any ongoing treatment known to affect hair growth
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SALT score<br>safety and tolerability
- Secondary Outcome Measures
Name Time Method SALT score